KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Account Payables: 2020-2023

Historic Change in Account Payables for Ginkgo Bioworks Holdings (DNA) over the last 2 years, with Jun 2023 value amounting to -$6.7 million.

  • Ginkgo Bioworks Holdings' Change in Account Payables rose 57.14% to -$6.7 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$18.5 million, marking a year-over-year decrease of 217.66%. This contributed to the annual value of $4.8 million for FY2024, which is 503.30% up from last year.
  • As of Q2 2023, Ginkgo Bioworks Holdings' Change in Account Payables stood at -$6.7 million, which was down 169.08% from $9.7 million recorded in Q1 2023.
  • Ginkgo Bioworks Holdings' 5-year Change in Account Payables high stood at $26.2 million for Q1 2022, and its period low was -$15.6 million during Q2 2022.
  • In the last 3 years, Ginkgo Bioworks Holdings' Change in Account Payables had a median value of -$3.1 million in 2021 and averaged -$1.0 million.
  • Over the last 5 years, Ginkgo Bioworks Holdings' Change in Account Payables had its largest YoY gain of 4,987.21% in 2022, and its largest YoY loss of 2,912.40% in 2022.
  • Ginkgo Bioworks Holdings' Change in Account Payables (Quarterly) stood at $4.3 million in 2020, then plummeted by 87.87% to $524,000 in 2021, then crashed by 2,912.40% to -$14.7 million in 2022, then spiked by 57.14% to -$6.7 million in 2023.
  • Its Change in Account Payables was -$6.7 million in Q2 2023, compared to $9.7 million in Q1 2023 and -$14.7 million in Q4 2022.